PRELUDE CAPITAL MANAGEMENT, LLC - SIENNA BIOPHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

SIENNA BIOPHARMACEUTICALS IN's ticker is SNNAQ and the CUSIP is 82622H108. A total of 34 filers reported holding SIENNA BIOPHARMACEUTICALS IN in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.6%.

Links
Filings
External links
Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of SIENNA BIOPHARMACEUTICALS IN
ValueSharesWeighting
Q2 2018$372,000
+46.5%
24,516
+75.4%
0.02%
+20.0%
Q4 2017$254,000
-46.1%
13,974
-34.1%
0.02%
-52.4%
Q3 2017$471,000–21,189–0.04%–
 Download
Other shareholders

There were no reported owners of SIENNA BIOPHARMACEUTICALS IN in Q3 2017.

NameSharesValueWeighting ↓
View complete list of SIENNA BIOPHARMACEUTICALS IN shareholders